Patent-family-84389004

Patent Number: WO-2024121130-A1

Publication Year: 2024

Application Year: 2023

Priority Year: 2022

Jurisdictions: WO

Status: N/A

Inventors:

KNUTSEN LARS J S KELLY NICHOLAS MICHAEL SARASWAT NEERJA HAMLYN RICHARD

Applicants:

  1. NMD PHARMA AS
  2. [NORA names: Other Companies; Private Research]

Abstract

The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the CIC-1 ion channel.

Patent Family Records (1)

COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

NMD PHARMA AS KNUTSEN LARS J S, KELLY NICHOLAS MICHAEL, SARASWAT NEERJA, (...more)

2024, WO-2024121130-A1

Data Provider: Digital Science